Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quick-starting of Quadriphasic Estradiol Valerate/Dienogest vs Ethinylestradiol/Gestodene for Ovulation Inhibition
NCT06396208Completed
- Sponsor
- Chulalongkorn University
- Start
- May 2024
- Primary completion
- Oct 2024
- Countries
- 1
01
Overview
Randomised, single-blind trial of estradiol valerate and dienogest in contraception (2 arms), sponsored by Chulalongkorn University. Primary endpoint: Rate of ovulation inhibition and classify ovarian activities using transvaginal ultrasound. Started May 2024; status: completed.
02
Drugs
estradiol valeratedienogest
03
Conditions
contraception
Beyond the preview
Go deeper on NCT06396208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06396208.